ETON 241220 10.00C (ETON241220C10000) Stock Options, News & Quotes

Account Info

Log Out

US OptionsDetailed Quotes

ETON241220C10000

Watchlist

2.75
0.000.00%

15min DelayTrading Dec 20 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Craig-Hallum Initiates Eton Pharmaceutical(ETON.US) With Buy Rating
Moomoo NewsDec 20 14:31 ET · Ratings
Eton Pharmaceuticals Closes Acquisition Of Increlex(R) (Mecasermin Injection) >ETON
Dow JonesDec 20 06:50 ET
Express News | Eton Pharmaceuticals Closes Acquisition of Increlex® (Mecasermin Injection)
ReutersDec 20 06:50 ET
Eton Pharmaceuticals Closes Acquisition of Increlex (Mecasermin Injection)
Eton PharmaceuticalDec 20 00:00 ET
Eton Pharmaceuticals Announced The Full Readout From The Clinical Trial Evaluating PKU GOLIKE As A Protein Substitute For Phenylketonuria In Patients During Prolonged Fasting Periods
BenzingaDec 17 06:51 ET
Express News | Eton Pharmaceuticals Announces Final Readout of Pku Golike® Clinical Trial
ReutersDec 17 06:50 ET

Comments

Trytosaveabit

Dec 20 05:51

Update

$Eton Pharmaceutical (ETON.US)$ Reuters
just
Eton Pharmaceuticals Closes Acquisition of Increlex® (Mecasermin Injection)

Trytosaveabit

Dec 17 05:57

Update

$Eton Pharmaceutical (ETON.US)$ Eton Pharmaceuticals Announced The Full Readout From The Clinical Trial Evaluating PKU GOLIKE As A Protein Substitute For Phenylketonuria In Patients During Prolonged Fasting Periods
Benzinga· 5 mins ago1min
The study demonstrated that PKU GOLIKE, administered as the last daily dose and compared to standard amino acid protein substitutes, improved metabolic control by reducing harmful phenylalanine (Phe) levels and increasing beneficial tyrosine (Tyr) levels,...

Jaguar8

Nov 25 05:54

NEWS

$Eton Pharmaceutical (ETON.US)$
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)
Eton Pharmaceuticals has acquired U.S. rights to Amglidia (glyburide oral suspension) from AMMTeK for treating neonatal diabetes mellitus.
The product, already approved by the European Medicines Agency since 2018, has received Orphan Drug Designation from the FDA. Amglidia is a patented liquid formulation targeting approximately 300 U.S. patients with neonatal dia...

Trytosaveabit

Nov 25 05:53

Update

$Eton Pharmaceutical (ETON.US)$ Reuters· 2 mins ago
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)

Trytosaveabit

Oct 8 17:43

New form 4

$Eton Pharmaceutical (ETON.US)$